• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,237.99 -160.73
( -0.21%)
Global Indices
Nasdaq
50,087.63 373.42
(0.75%)
Dow Jones
7,522.46 57.21
(0.77%)
Hang Seng
61,141.50 -1,512.55
(-2.41%)
Nikkei 225
10,172.40 -200.53
(-1.93%)
Forex
USD-INR
95.64 0.03
(0.04%)
EUR-INR
112.06 -0.23
(-0.21%)
GBP-INR
129.33 -0.17
(-0.13%)
JPY-INR
0.61 0.00
(-0.10%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

Bliss GVS Pharma consolidated net profit rises 128.96% in the March 2026 quarter
May 13,2026
Net profit of Bliss GVS Pharma rose 128.96% to Rs 35.58 crore in the quarter ended March 2026 as against Rs 15.54 crore during the previous quarter ended March 2025. Sales rose 29.80% to Rs 256.99 crore in the quarter ended March 2026 as against Rs 197.99 crore during the previous quarter ended March 2025.

For the full year,net profit rose 53.18% to Rs 129.13 crore in the year ended March 2026 as against Rs 84.30 crore during the previous year ended March 2025. Sales rose 14.50% to Rs 927.11 crore in the year ended March 2026 as against Rs 809.73 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales256.99197.99 30 927.11809.73 15
OPM %17.2910.65 -17.6915.65 -
PBDT53.5931.48 70 225.56155.06 45
PBT44.9223.44 92 192.08125.64 53
NP35.5815.54 129 129.1384.30 53